Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36

3 Segmentation of North America Market by Virus Type 40
3.1 Market Overview by Virus Type 40
3.2 HSV-1 42
3.3 HSV-2 43

4 Segmentation of North America Market by Drug Type 44
4.1 Market Overview by Drug Type 44
4.2 Acyclovir 47
4.3 Valacyclovir 48
4.4 Famciclovir 49
4.5 Other Drugs 50

5 Segmentation of North America Market by Route of Administration 52
5.1 Market Overview by Route of Administration 52
5.2 Oral 54
5.3 Topical 55
5.4 Injection 56

6 Segmentation of North America Market by Patient Gender 57
6.1 Market Overview by Patient Gender 57
6.2 Female 59
6.3 Male 60

7 Segmentation of North America Market by Distribution Channel 61
7.1 Market Overview by Distribution Channel 61
7.2 Retail Pharmacies 63
7.3 Hospital Pharmacies 64
7.4 Online Pharmacies 65
7.5 Drug Stores 66

8 North America Market 2022-2032 by Country 67
8.1 Overview of North America Market 67
8.2 U.S. 70
8.3 Canada 75
8.4 Mexico 77

9 Competitive Landscape 79
9.1 Overview of Key Vendors 79
9.2 New Product Launch, Partnership, Investment, and M&A 82
9.3 Company Profiles 83
Abbott 83
ADLEY FORMULATIONS 85
Aurobindo Pharma Ltd. 86
Avet Pharmaceuticals Inc. 87
Bausch Health Companies 88
Centurion Remedies 89
Cipla Ltd. 90
Eli Lilly & Company 91
Finecure Pharmaceuticals 92
GlaxoSmithKline Plc 93
Glenmark Pharmaceuticals 94
Macleods Pharmaceuticals 95
Medico Remedies 96
Merck & Co., Inc. 97
Novartis AG 98
Pfizer 99
Reddy’s Laboratories 100
Sanofi SA 101
Teva Pharmaceutical Industries Ltd. 102
Torrent Pharma 103
Viatris Inc. 104
Zeelab Pharmacy 105
Zydus Pharmaceuticals, Inc. 106
RELATED REPORTS 107



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 16
Figure 4. North America Genital Herpes Treatment Market, 2022-2032, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Genital Herpes Treatment Market 25
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million 28
Figure 8. Primary Restraints and Impact Factors of North America Genital Herpes Treatment Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of North America Genital Herpes Treatment Market 36
Figure 11. Breakdown of North America Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue 41
Figure 12. North America Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%) 41
Figure 13. North America Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn 42
Figure 14. North America Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn 43
Figure 15. Breakdown of North America Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue 45
Figure 16. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%) 45
Figure 17. North America Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn 47
Figure 18. North America Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn 48
Figure 19. North America Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn 49
Figure 20. North America Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn 50
Figure 21. Breakdown of North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue 53
Figure 22. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%) 53
Figure 23. North America Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn 54
Figure 24. North America Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn 55
Figure 25. North America Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn 56
Figure 26. Breakdown of North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue 58
Figure 27. North America Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%) 58
Figure 28. North America Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn 59
Figure 29. North America Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn 60
Figure 30. Breakdown of North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue 62
Figure 31. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 62
Figure 32. North America Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn 63
Figure 33. North America Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn 64
Figure 34. North America Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn 65
Figure 35. North America Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 66
Figure 36. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue 68
Figure 37. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 69
Figure 38. Percentage of LGBT in Total Population in U.S., 2012-2021 71
Figure 39. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018 72
Figure 40. Healthcare Cost by STI Type in U.S. in 2018 73
Figure 41. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn 73
Figure 42. Canada Genital Herpes Treatment Market, 2022-2032, $ mn 75
Figure 43. Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn 77
Figure 44. Growth Stage of North America Genital Herpes Treatment Industry over the Forecast Period 79

List of Tables

List of Tables:

Table 1. Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market 32
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 40
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 44
Table 8. Side Effects of Genital Herpes Medications 44
Table 9. Vaccine Pipelines for Herpes 51
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn 52
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn 57
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 61
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn 68
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 74
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 74
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 74
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 76
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 76
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 76
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 78
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 78
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 78
Table 23. Abbott: Company Snapshot 83
Table 24. Abbott: Business Segmentation 84
Table 25. Abbott: Product Portfolio 84